Skip to main content
Top
Published in: Infectious Diseases and Therapy 1/2022

Open Access 01-02-2022 | Cancer Therapy | Brief Report

Sepsis in Pediatric Cancer: Does Gender Matter? A 20-Year Retrospective Study

Authors: Andreas Meryk, Gabriele Kropshofer, Caroline Bargehr, Miriam Knoll, Benjamin Hetzer, Cornelia Lass-Flörl, Roman Crazzolara

Published in: Infectious Diseases and Therapy | Issue 1/2022

Login to get access

Abstract

Introduction

Gender plays an active role in the incidence and outcome of many infectious and malignant diseases. However, there is still no study examining sex differences for developing bloodstream infections (BSIs) in pediatric patients with cancer. We sought to identify potential gender-specific risk factors for BSIs.

Methods

Data were retrospectively analyzed from 621 pediatric patients treated for childhood cancer in a tertiary single center between 1 January 2000 and 31 June 2018. After central venous access device (CVAD) placement, patients were followed up until CVAD was removed or at the most for 1 year. We calculated the gender-specific prevalence for BSIs and compared the causative bacterial strains.

Results

Of 621 pediatric patients with cancer (283 girls [45.6%] and 338 boys [54.4%]), 110 patients (41 girls [37.3%] and 69 boys [62.7%]) were identified with a total of 134 BSIs. Girls and boys had a similar incidence for BSI (13%) within the first 3 months of therapy, after which the risk for BSI increased significantly for boys (34% versus 21%, boys versus girls, P = 0.025). Moreover, BSI with gram-positive bacteria affected boys nearly twice as often as girls (29.8% versus 56.5%, girls versus boys).

Conclusions

Future clinical awareness of hygiene-related BSIs in boys could be helpful in identifying areas for improvement.
Literature
1.
go back to reference Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.CrossRef Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.CrossRef
2.
go back to reference Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16(10):626–38.CrossRef Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16(10):626–38.CrossRef
3.
go back to reference Williams LA, Richardson M, Marcotte EL, Poynter JN, Spector LG. Sex ratio among childhood cancers by single year of age. Pediatr Blood Cancer. 2019;66(6):e27620.CrossRef Williams LA, Richardson M, Marcotte EL, Poynter JN, Spector LG. Sex ratio among childhood cancers by single year of age. Pediatr Blood Cancer. 2019;66(6):e27620.CrossRef
4.
go back to reference Meryk A, Kropshofer G, Hutter J, et al. Benefits of risk-adapted and mould-specific antifungal prophylaxis in childhood leukaemia. Br J Haematol. 2020;191:816–24.CrossRef Meryk A, Kropshofer G, Hutter J, et al. Benefits of risk-adapted and mould-specific antifungal prophylaxis in childhood leukaemia. Br J Haematol. 2020;191:816–24.CrossRef
5.
go back to reference Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49(1):1–45.CrossRef Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49(1):1–45.CrossRef
6.
go back to reference Meryk A, Kropshofer G, Bargehr C, et al. Which type of empiric antibiotic therapy is appropriate? A 20-year retrospective study of bloodstream infections in childhood cancer. Infect Dis Ther. 2021;10:789–800.CrossRef Meryk A, Kropshofer G, Bargehr C, et al. Which type of empiric antibiotic therapy is appropriate? A 20-year retrospective study of bloodstream infections in childhood cancer. Infect Dis Ther. 2021;10:789–800.CrossRef
7.
go back to reference O’Connor D, Bate J, Wade R, et al. Infection-related mortality in children with acute lymphoblastic leukemia: an analysis of infectious deaths on UKALL2003. Blood. 2014;124(7):1056–61.CrossRef O’Connor D, Bate J, Wade R, et al. Infection-related mortality in children with acute lymphoblastic leukemia: an analysis of infectious deaths on UKALL2003. Blood. 2014;124(7):1056–61.CrossRef
8.
go back to reference Watson RS, Carcillo JA, Linde-Zwirble WT, Clermont G, Lidicker J, Angus DC. The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med. 2003;167(5):695–701.CrossRef Watson RS, Carcillo JA, Linde-Zwirble WT, Clermont G, Lidicker J, Angus DC. The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med. 2003;167(5):695–701.CrossRef
9.
go back to reference Tasker RC. Gender differences and critical medical illness. Acta Paediatr. 2000;89(5):621–3.CrossRef Tasker RC. Gender differences and critical medical illness. Acta Paediatr. 2000;89(5):621–3.CrossRef
10.
go back to reference Humphreys H, Fitzpatick F, Harvey BJ. Gender differences in rates of carriage and bloodstream infection caused by methicillin-resistant Staphylococcus aureus: are they real, do they matter and why? Clin Infect Dis. 2015;61(11):1708–14.PubMed Humphreys H, Fitzpatick F, Harvey BJ. Gender differences in rates of carriage and bloodstream infection caused by methicillin-resistant Staphylococcus aureus: are they real, do they matter and why? Clin Infect Dis. 2015;61(11):1708–14.PubMed
Metadata
Title
Sepsis in Pediatric Cancer: Does Gender Matter? A 20-Year Retrospective Study
Authors
Andreas Meryk
Gabriele Kropshofer
Caroline Bargehr
Miriam Knoll
Benjamin Hetzer
Cornelia Lass-Flörl
Roman Crazzolara
Publication date
01-02-2022
Publisher
Springer Healthcare
Keyword
Cancer Therapy
Published in
Infectious Diseases and Therapy / Issue 1/2022
Print ISSN: 2193-8229
Electronic ISSN: 2193-6382
DOI
https://doi.org/10.1007/s40121-021-00549-w

Other articles of this Issue 1/2022

Infectious Diseases and Therapy 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine